These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 30175120)

  • 1. Identification of Key Genes and Pathways in Triple-Negative Breast Cancer by Integrated Bioinformatics Analysis.
    Dong P; Yu B; Pan L; Tian X; Liu F
    Biomed Res Int; 2018; 2018():2760918. PubMed ID: 30175120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of key genes as potential biomarkers for triple‑negative breast cancer using integrating genomics analysis.
    Zhong G; Lou W; Shen Q; Yu K; Zheng Y
    Mol Med Rep; 2020 Feb; 21(2):557-566. PubMed ID: 31974598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of differentially expressed genes between triple and non-triple-negative breast cancer using bioinformatics analysis.
    Zhai Q; Li H; Sun L; Yuan Y; Wang X
    Breast Cancer; 2019 Nov; 26(6):784-791. PubMed ID: 31197620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of CCNE1 confers a poorer prognosis in triple-negative breast cancer identified by bioinformatic analysis.
    Yuan Q; Zheng L; Liao Y; Wu G
    World J Surg Oncol; 2021 Mar; 19(1):86. PubMed ID: 33757543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis.
    Ma J; Chen C; Liu S; Ji J; Wu D; Huang P; Wei D; Fan Z; Ren L
    Cancer Gene Ther; 2022 Nov; 29(11):1578-1589. PubMed ID: 35474355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KEGG-expressed genes and pathways in triple negative breast cancer: Protocol for a systematic review and data mining.
    Chen J; Liu C; Cen J; Liang T; Xue J; Zeng H; Zhang Z; Xu G; Yu C; Lu Z; Wang Z; Jiang J; Zhan X; Zeng J
    Medicine (Baltimore); 2020 May; 99(18):e19986. PubMed ID: 32358373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated network analysis and machine learning approach for the identification of key genes of triple-negative breast cancer.
    Naorem LD; Muthaiyan M; Venkatesan A
    J Cell Biochem; 2019 Apr; 120(4):6154-6167. PubMed ID: 30302816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel biomarkers identified in triple-negative breast cancer through RNA-sequencing.
    Chen YL; Wang K; Xie F; Zhuo ZL; Liu C; Yang Y; Wang S; Zhao XT
    Clin Chim Acta; 2022 Jun; 531():302-308. PubMed ID: 35504321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Features of Triple Negative Breast Cancer: Microarray Evidence and Further Integrated Analysis.
    He J; Yang J; Chen W; Wu H; Yuan Z; Wang K; Li G; Sun J; Yu L
    PLoS One; 2015; 10(6):e0129842. PubMed ID: 26103053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Key Prognostic Genes of Triple Negative Breast Cancer by LASSO-Based Machine Learning and Bioinformatics Analysis.
    Chen DL; Cai JH; Wang CCN
    Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
    Yang C; Gong A
    Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
    [No Abstract]   [Full Text] [Related]  

  • 12. Integrated analysis of differentially expressed genes and pathways in triple‑negative breast cancer.
    Peng C; Ma W; Xia W; Zheng W
    Mol Med Rep; 2017 Mar; 15(3):1087-1094. PubMed ID: 28075450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer.
    Qiu P; Guo Q; Yao Q; Chen J; Lin J
    PLoS One; 2021; 16(11):e0254283. PubMed ID: 34797837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Potential Key Genes Associated With the Pathogenesis, Metastasis, and Prognosis of Triple-Negative Breast Cancer on the Basis of Integrated Bioinformatics Analysis.
    Zhao B; Xu Y; Zhao Y; Shen S; Sun Q
    Front Oncol; 2020; 10():856. PubMed ID: 32596149
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunity and Extracellular Matrix Characteristics of Breast Cancer Subtypes Based on Identification by T Helper Cells Profiling.
    Zhou Y; Tian Q; Gao H; Zhu L; Zhang Y; Zhang C; Yang J; Wang B
    Front Immunol; 2022; 13():859581. PubMed ID: 35795662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatics Analysis Identifies IL6ST as a Potential Tumor Suppressor Gene for Triple-Negative Breast Cancer.
    Jia R; Weng Y; Li Z; Liang W; Ji Y; Liang Y; Ning P
    Reprod Sci; 2021 Aug; 28(8):2331-2341. PubMed ID: 33650093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of Candidate Genes and Pathways in Basal/TNBC Patients by Integrated Analysis.
    Liu Q; Song X; Liu Z; Yu Z
    Technol Cancer Res Treat; 2021; 20():15330338211019506. PubMed ID: 34184566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics analysis of key genes in triple negative breast cancer and validation of oncogene PLK1.
    Ren Y; Deng R; Zhang Q; Li J; Han B; Ye P
    Ann Transl Med; 2020 Dec; 8(24):1637. PubMed ID: 33490149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of key differentially expressed genes between ER-positive/HER2-negative breast cancer and ER-negative/HER2-negative breast cancer using integrated bioinformatics analysis.
    Gan S; Dai H; Li R; Liu W; Ye R; Ha Y; Di X; Hu W; Zhang Z; Sun Y
    Gland Surg; 2020 Jun; 9(3):661-675. PubMed ID: 32775256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of
    Wang F; Cao X; Yin L; Wang Q; He Z
    DNA Cell Biol; 2020 Oct; 39(10):1813-1824. PubMed ID: 32816580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.